Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
Abstract Background The aim of this study is to examine the occurrence of comorbidities at the time of first diagnosis of gout compared with matched population controls, overall and by sex, as well as to examine the crude and age-standardized prevalence of these comorbidities in men and women with g...
Main Authors: | Panagiota Drivelegka, Valgerdur Sigurdardottir, Anna Svärd, Lennart T. H. Jacobsson, Mats Dehlin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13075-018-1596-x |
Similar Items
-
The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors—30 years follow-up of the Malmö Preventive Project
by: Tahzeeb Fatima, et al.
Published: (2020-10-01) -
Correction to: Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
by: Panagiota Drivelegka, et al.
Published: (2018-09-01) -
Treatment approaches and adherence to urate-lowering therapy for patients with gout
by: Aung T, et al.
Published: (2017-04-01) -
Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
by: Mengying Sun, et al.
Published: (2018-05-01) -
Prevention of arthritis attacks in the use of urate-lowering therapy in patients with gout
by: M. N. Chikina
Published: (2019-01-01)